These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33932024)

  • 1. Unexpected hearing improvement after treatment with valganciclovir in a child with congenital cytomegalovirus infection.
    Palma S; Mazzoni L; Roversi MF; Botti C; Monzani D; Berardi A; Genovese E
    Folia Med (Plovdiv); 2021 Apr; 63(2):297-301. PubMed ID: 33932024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
    Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P;
    J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir.
    McCrary H; Sheng X; Greene T; Park A
    Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():124-127. PubMed ID: 30611098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multifaceted Clinical Characteristics of Congenital Cytomegalovirus Infection: From Pregnancy to Long-Term Outcomes.
    Kim Y; Kim YM; Kim DR; Kim HG; Sung JH; Choi SJ; Oh SY; Kim YJ; Chang YS; Kim D; Kim JS; Moon IJ; Roh CR
    J Korean Med Sci; 2023 Aug; 38(32):e249. PubMed ID: 37582499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
    Yilmaz Çiftdogan D; Vardar F
    J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neonate with reduced cytomegalovirus DNA copy number and marked improvement of hearing in the treatment of congenital cytomegalovirus infection.
    Hayakawa J; Kawakami Y; Takeda S; Ozawa H; Fukazawa R; Takase M; Fukunaga Y
    J Nippon Med Sch; 2012; 79(6):471-7. PubMed ID: 23291847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.
    Dorfman L; Amir J; Attias J; Bilavsky E
    Eur J Pediatr; 2020 May; 179(5):807-812. PubMed ID: 31927626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection.
    Ohyama S; Morioka I; Fukushima S; Yamana K; Nishida K; Iwatani S; Fujioka K; Matsumoto H; Imanishi T; Nakamachi Y; Deguchi M; Tanimura K; Iijima K; Yamada H
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss.
    Pasternak Y; Ziv L; Attias J; Amir J; Bilavsky E
    J Pediatr; 2018 Aug; 199():166-170. PubMed ID: 29605391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?
    Whitley RJ
    Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S60-S63. PubMed ID: 31205247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic congenital Cytomegalovirus deafness: the impact of a six-week course of antiviral treatment on hearing improvement.
    Mazzaferri F; Cordioli M; Conti M; Storato S; Be G; Biban P; Concia E; Merighi M
    Infez Med; 2017 Dec; 25(4):347-350. PubMed ID: 29286014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: An observational study.
    Bartlett AW; Hall BM; Palasanthiran P; McMullan B; Shand AW; Rawlinson WD
    J Clin Virol; 2018 Nov; 108():121-125. PubMed ID: 30300787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled Trial.
    Chung PK; Schornagel FAJ; Soede W; van Zwet EW; Kroes ACM; Oudesluys-Murphy AM; Vossen ACTM
    J Pediatr; 2024 May; 268():113945. PubMed ID: 38336204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Minimally symptomatic" congenital cytomegalovirus infection: latest data and emerging concepts.
    Howard A; Nishikawa JK; Sánchez PJ
    Curr Opin Pediatr; 2024 Aug; 36(4):480-488. PubMed ID: 38747205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
    Amir J; Wolf DG; Levy I
    Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Audiologic Outcomes in Twins with Congenital Cytomegalovirus Infection.
    Botti C; Palma S; Roversi MF; Monzani D; Berardi A; Genovese E
    J Int Adv Otol; 2020 Apr; 16(1):130-133. PubMed ID: 32209524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing outcomes in children with congenital cytomegalovirus infection: From management controversies to lack of parents' knowledge.
    Aldè M; Caputo E; Di Berardino F; Ambrosetti U; Barozzi S; Piatti G; Zanetti D; Pignataro L; Cantarella G
    Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111420. PubMed ID: 36563581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009-2015.
    Leung J; Dollard SC; Grosse SD; Chung W; Do T; Patel M; Lanzieri TM
    Clin Ther; 2018 Mar; 40(3):430-439.e1. PubMed ID: 29397198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful valganciclovir treatment initiated beyond 60 days of age in a preterm infant with congenital cytomegalovirus disease.
    Okahashi A; Hijikata M; Seimiya A; Nagano N; Yokota H; Kimura Y; Morioka I
    Pediatr Int; 2024; 66(1):e15755. PubMed ID: 38563289
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.
    Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y
    J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.